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ABSTRACT
DNA topoisomerases manage chromosome super-
coiling and organization in all forms of life. Gyrase, a
prokaryotic heterotetrameric type IIA topo, intro-
duces negative supercoils into DNA by an
ATP-dependent strand passage mechanism.
All gyrase orthologs rely on a homologous set of
catalytic domains for function; however, these
enzymes also can possess species-specific auxil-
iary regions. The gyrases of many gram-negative
bacteria harbor a 170-amino acid insertion of
unknown architecture and function in the metal-
and DNA-binding TOPRIM domain of the GyrB
subunit. We have determined the structure of the
212kDa Escherichia coli gyrase DNA binding and
cleavage core containing this insert to 3.1A ˚ reso-
lution. We find that the insert adopts a novel,
extended fold that braces the GyrB TOPRIM
domain against the coiled-coil arms of its partner
GyrA subunit. Structure-guided deletion of the
insert greatly reduces the DNA binding, supercoiling
and DNA-stimulated ATPase activities of gyrase.
Mutation of a single amino acid at the contact
point between the insert and GyrA more modestly
impairs supercoiling and ATP turnover, and does
not affect DNA binding. Our data indicate that the
insert has two functions, acting as a steric buttress
to pre-configure the primary DNA-binding site, and
serving as a relay that may help coordinate commu-
nication between different functional domains.
INTRODUCTION
DNA topoisomerases (topos) are ubiquitous, essential
enzymes that manage supercoiling homeostasis and
chromosome topology in all forms of life. Most organisms
possess a complement of multiple topoisomerase types,
each of which is responsible for a different cellular task
(1–3). For example, in Escherichia coli, the type IA topo I
relaxes negative supercoils (4–6), whereas its paralog, topo
III, helps resolve catenanes and Holliday junctions
produced by replication and recombination (7,8).
Catenanes and knots are also unlinked by the type IIA
enzyme, topo IV (9–11), while its a paralogous counter-
part, gyrase, negatively supercoils DNA (5,12).
Type IIA topos, including gyrase, topo IV and eukary-
otic topo II, use several conserved catalytic domains to
actively pass one duplex DNA through a double-stranded
break in another. Strand passage is coordinated by a
so-called ‘two-gate’ mechanism, in which the transported
DNA duplex (the T-segment) is navigated through
the cleaved DNA (the G-segment) by the movement
of multiple, dissociable subunit interfaces, or ‘gates’
(13–16). The reaction begins with the binding of
G-segment DNA to the central region of the enzyme,
the DNA-gate, an interface composed of a pair of
metal-binding topo/primase (TOPRIM) domains and
two dimer-related winged-helix domains (WHDs).
T-segment capture is accomplished upon the nucleotide-
dependent dimerization a second interface in the protein,
the ATP-gate (17–21). This event stimulates G-segment
cleavage, a reaction catalyzed by both a catalytic
tyrosine residue present on each WHD and a pair of
divalent metal ions liganded by each TOPRIM fold
(22–27); ATP hydrolysis and release of inorganic phos-
phate facilitate passage of the T-segment through the
broken DNA (28–31). At the end of the topoisomerase
cycle, the T-segment exits the enzyme through a third
subunit interface (the C-gate) formed by a pair of small
globular domains that each sit at the terminus of a
coiled-coil segment (14,16,22,32).
In bacterial type IIA topos, the gyrB and parE genes
encode the ATPase and TOPRIM domains of gyrase and
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encoded by gyrA and parC (Figure 1A). The GyrA and
ParC subunits also contain a C-terminal, DNA-binding
domain that that contributes to the differential substrate
speciﬁcities of the two paralogs (33,34). Thus far, nearly
all of the domains found within type IIA topos have been
visualized by X-ray crystallography. One exception is a
170-amino acid region found within the GyrB subunit in
a number of bacterial lineages, including proteobacteria,
acidobacteria, chlamydia and aquiﬁcales (Figure 1B).
This insertion, which shares no sequence homology with
known proteins, has been proposed to form a distinct
structural domain that participates in DNA binding
(35,36); however, the overall architecture of the insert
and its exact role in gyrase function have remained
enigmatic.
As a means to understand the role of the insert in
gyrase’s mechanism, we determined the 3.1A ˚ crystal
structure of the E. coli GyrB insert in the context of the
heterotetrameric GyrB–GyrA DNA binding and cleavage
core. This construct encompasses the TOPRIM and insert
domains of GyrB and the WHD and C-gate region of
GyrA. The insert, which adopts a novel fold, forms an
extended element that contacts the coiled-coil arms of its
GyrA partner. Using the structure as a guide, we designed
precise deletion and point mutants of the insert and found
that these variants are defective for a wide range of gyrase
activities. Our results indicate that the insert acts as a
Figure 1. Escherichia coli gyrase primary and secondary structure. (A) GyrA and GyrB domain organization. Catalytic modules of E. coli gyrase are
indicated as bars. The regions encompassed by the GyrBA fusion are indicated. (B) Alignment of the GyrB insert region. Selected GyrB genes were
aligned using MUSCLE (68,69). Organisms with GyrB genes containing an insert are shown in blue; those with GyrB genes lacking inserts, in black.
Regions corresponding to the hook and insert are indicated, as are secondary structure elements as identiﬁed in the structure (bars—a-helices;
arrows—b-sheets). Insert elements are numbered by secondary structure element as in Figure 3B. Amino acid numbering is at right. The alignment is
colored by ClustalX score within the two major subgroups (GyrBs with and without inserts). Note the poor conservation of the insert compared to
the hook region. This ﬁgure was prepared using Jalview (70).
Nucleic Acids Research, 2010,Vol.38, No. 21 7831buttressing element to help pre-orient the DNA gate for
efﬁcient G-segment binding, and that it further aids strand
passage, possibly by acting as an allosteric relay between
distal enzyme gates.
MATERIALS AND METHODS
Construction of a GyrB–GyrA fusion protein for
crystallography
To simplify crystallization of a tetrameric GyrB2GyrA2
construct, we created a truncated GyrB–GyrA protein
that fuses amino acids 1–525 of GyrA directly to
residues 388–804 of GyrB. The coding region for this con-
struct was cloned into a ligation-independent cloning
plasmid behind an N-terminal, tobacco etch protease
(TEV)-cleavable, hexahistidine-maltose binding protein
(His6-MBP) tag, creating the pLIC172-escoGyrBAfus
vector.
Expression and puriﬁcation of selenomethionine-
derivatized E. coli GyrBA-fus
For expression, pLIC172-escoGyrBAfus was transformed
into E. coli BL21-CodonPlus(DE3)-RIL competent cells
(Stratagene). One-Liter cultures were grown in minimal
media in 2l bafﬂed ﬂasks at 37 C to an optical density
(A600nm) of 0.4–0.6. An amino acid cocktail containing
leucine, isoleucine, valine, phenylalanine, lysine, threo-
nine and seleno-methionine was added to shut down
methionine biosynthesis (37), cultures were transferred
to 18–20 C for 30min, and protein expression was
induced by the addition of 0.25mM isopropyl-b-D-
thiogalactopyranoside (IPTG). Cells were harvested by
centrifugation after  16h, resuspended in buffer A8000
(20mM HEPES pH 7.5, 800mM NaCl, 30mM imidazole
pH 8.0, 10% glycerol, 1mM PMSF, 1mg/ml pepstatin A,
1mg/ml leupeptin, 5mM bME) and frozen dropwise in
liquid nitrogen.
For protein puriﬁcation, cell pellets were thawed and
sonicated, and the lysate clariﬁed by centrifugation. The
lysate was then passed over a Ni
2+-afﬁnity column (GE)
and washed with buffer A8000, followed by buffer A4000
(buffer A8000 containing 400mM NaCl). Protein was
eluted with buffer B4000 (buffer A4000 containing
500mM imidazole), concentrated using Amicon centrifu-
gal ﬁlter devices, mixed with His6-tagged TEV protease
(38) using a ratio of 1:50–1:10 (wt/wt) TEV protease:pro-
tein, and dialyzed overnight at 4 C in a 10000 molecular
weight cut-off (MWCO) SlideAlyzer (Pierce) against
buffer A4000. The dialyzed mixture was passed over a
Ni
2+-afﬁnity column, and the ﬂow-through was collected,
concentrated and exchanged into buffer C1250 (20mM
HEPES pH 7.5, 125mM NaCl, 1mM EDTA, 10%
glycerol, 1mM TCEP). The sample was then adsorbed
to an anion exchange column (HiTrap HQ, GE)
equilibrated in buffer C1250 and eluted using a 125–
300mM NaCl gradient over 60 column volumes. Peak
fractions were pooled, concentrated and run over a size
exclusion column (Sephacryl S300, GE) equilibrated in
buffer SE0 (50mM HEPES pH 7.5, 500mM KCl, 1mM
EDTA, 10% glycerol, 1mM TCEP) to remove aggregated
species. Fractions corresponding to the dimer peak
were pooled and concentrated, then dialyzed into
crystallization buffer (10mM HEPES pH 7.5, 50mM
KCl and 1mM TCEP) using a Harvard Apparatus
MicroDispoDialyzer.
Crystallization of GyrBA-fus
Crystals of selenomethionine-derivatized GyrBA-fus were
grown by hanging-drop vapor diffusion at 18 C by mixing
0.1ml of protein (1.8mg/ml) with 0.1ml of crystallization
solution (90mM imidazole pH 8.0, 11% isopropanol,
18mM MgCl2, 10mM spermidine, 3% pentaerythritol
ethoxylate 15/4). Crystals grew as 3D trapezoids with
two wedge-like ends abutting a thicker, central region.
Crystals were cryoprotected by exchanging the drop into
harvest solution (2% pentaerythritol ethoxylate 15/4,
6.5mM spermine, 60mM imidazole pH 8.0, 12mM
MgCl2, 12.1% isopropanol, 6.mM HEPES pH 7.5,
26.2mM KCl, 1mM TCEP, 20% PEG400) prior to har-
vesting and ﬂash-freezing in liquid nitrogen.
Structure determination
Diffraction data were collected from a single crystal at the
Advanced Photon Source microfocus beamline NE-CAT
24-ID-E at the selenium edge (0.9792A ˚ ). Multiple
volumes of the crystals were exposed during data collec-
tion; regions that yielded data of the highest quality (in
terms of mosaicity and I/s) were merged and processed in
HKL2000 (39) (Table 1). A combination of molecular re-
placement (MR) and single-wavelength anomalous disper-
sion (SAD) as implemented in PHENIX were used to
determine phases (40). A MR solution was obtained
using the structure of the E. coli GyrA N-terminal
domain (PDBID 1AB4) as a search model (41). These
MR phases were used to locate selenium sites, which
were then used for SAD phasing (40). The TOPRIM
and insert domains, which were not part of the MR
search model, were built de novo into SAD-phased maps
using COOT (42). Rounds of manual rebuilding and re-
ﬁnement were accomplished using COOT and PHENIX
(40,42). TLS groups for reﬁnement were chosen using the
TLSMD server (43,44). Stereochemistry and clashes were
resolved using MolProbity and COOT (42,45).
Cloning and expression of GyrA and GyrB constructs for
biochemical studies
The coding region for full-length E. coli GyrA and GyrB,
the E. coli GyrB insert (Ala560–Ser735) and CTDless
GyrA (Ser2–Thr522, also called GyrACTD) were
ampliﬁed from either genomic DNA or pre-existing
vectors and cloned into either vector pLIC172 (an
in-house LIC vector) or pET28b (Novagen). Both
vectors include N-terminal hexahistidine (His6) tags
upstream of TEV cleavage sites; pLIC172 also contains
a maltose-binding protein (MBP) tag between the His6
tag and the TEV site. GyrB point mutants H669A and
H669E were created using QuikChange (Stratagene). A
GyrB construct lacking the insert (GyrBinsert), in which
GyrB residues Thr565–Arg731 were replaced with a Gly–
Ser–Ser–Gly linker, was created by separately amplifying
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pression vector, then fusing them together in a second
PCR step.
Protein expression was carried out in either E. coli
BL21-CodonPlus(DE3)-RIL cells (Stratagene) or E. coli
Arctic Express cells (Stratagene). In general, 1l cultures
were grown at 37 Ci n2  YT media in 2l bafﬂed ﬂasks to
an A600nm of 0.4–0.6. Protein expression was induced
with 0.25–0.5mM IPTG. For GyrA and GyrACTD
expression, induction was carried out for 4h at 37 C.
All other proteins were expressed for 12–16h at 18–
20 C. Cells were harvested by centrifugation, resuspended
in speciﬁc buffers (see below), and frozen dropwise in
liquid nitrogen before storing at  80 C.
Puriﬁcation of wild-type E. coli GyrA
Frozen cells resuspended in buffer A1000 (50mM HEPES
pH 7.5, 20mM imidazole pH 8.0, 1000mM NaCl, 10%
glycerol, 2mM bME, 1mg/ml pepstatin A, 1mg/ml
leupeptin, 1mM PMSF) were sonicated and centrifuged,
and the clariﬁed lysate passed over a Ni
2+-afﬁnity column.
The column was washed with buffer A1000 followed by
buffer A100 (buffer A1000 containing only 100mM
NaCl). Protein was eluted with buffer B100 (buffer A100
containing 500mM imidazole). Peak fractions were
pooled, concentrated and incubated overnight at 4 C
with His6-tagged TEV protease as described for
GyrBA-fus. This mixture was then run through a Ni
2+-
afﬁnity column, and the ﬂow-through concentrated and
passed over a Sephacryl S300 gel ﬁltration column
equilibrated in 50mM HEPES pH 7.5, 400mM KCl,
1mM EDTA pH 8.0, 2mM bME, 10% glycerol.
Fractions containing GyrA were identiﬁed using SDS–
PAGE/Coomassie staining, then pooled and
concentrated. Glycerol was added to a ﬁnal concentration
of 19%, and protein aliquots were ﬂash-frozen in liquid
nitrogen and stored at  80 C. Final storage conditions
were 45mM HEPES pH 7.5, 360mM KCl, 0.9mM
EDTA pH 8.0, 1.8mM bME, 19% glycerol.
Puriﬁcation of wild-type, "insert, H669A and H669E
E. coli GyrB
Frozen cells expressing the appropriate proteins and re-
suspended in buffer A800 (20mM HEPES pH 7.5,
800mM NaCl, 30mM imidazole pH 8.0, 10% glycerol,
1mM PMSF, 1mg/ml pepstatin A, 1mg/ml leupeptin,
2mM bME) were thawed and sonicated and the lysate
clariﬁed by centrifugation. Clariﬁed lysate was passed
over a Ni
2+-afﬁnity column and washed with buffer
A800 followed by buffer A50 (buffer A800 containing
50mM NaCl). Bound protein was eluted from the Ni
2+
column directly to an anion exchange column (HiTrap
HQ) using buffer B50 (buffer A50 containing 500mM
imidazole). This column was then washed with buffer
C50 (20mM HEPES pH 7.5, 50mM NaCl, 1mM
EDTA, 10% glycerol, 2mM bME), and bound protein
eluted using a 24 column-volume gradient to 100%
buffer C500 (buffer C50 containing 500mM NaCl).
Fractions containing the protein of interest were identiﬁed
by SDS–PAGE/Coomassie staining, pooled and
concentrated by centrifugal ﬁltration. Following TEV
protease cleavage as per GyrBA-fus, the dialyzed protein
was passed over a second Ni
2+-afﬁnity column. The
ﬂow-through was collected, concentrated by centrifugal
ﬁltration, and passed over a Sephacryl S300 gel ﬁltration
column equilibrated in buffer SE (50mM HEPES pH 7.5,
500mM KCl, 1mM EDTA, 10% glycerol, 2mM bME).
For initial preps, individual fractions were tested for
activity. Fractions corresponding to the dimer and
monomer forms of the protein exhibited consistent, high
activity, and so only these fractions were pooled and
concentrated. Glycerol was added to concentrated frac-
tions to a ﬁnal concentration of 30%, and protein was
aliquoted and snap-frozen in liquid nitrogen and stored
at  80 C. Final storage conditions were 50mM HEPES
pH 7.5, 500mM KCl, 1mM EDTA pH 8.0, 2mM bME,
30% glycerol.
Puriﬁcation of the isolated E. coli GyrB-insert
For protein puriﬁcation, cells resuspended in buffer A800
were sonicated and centrifuged, and the clariﬁed lysate
passed over a Ni
2+-afﬁnity column. The column was
washed with buffer A800 followed by buffer A400.
Protein was then eluted with buffer B400 (buffer A400
containing 500mM imidazole), and peak fractions were
pooled, concentrated and treated with TEV protease as
Table 1. Data collection, reﬁnement and stereochemistry
Data collection
Resolution (Angstroms) (last shell) 40.0–3.1 (3.2–3.1)
Wavelength (Angstroms) 0.97920
Space group C2221
Unit cell dimensions (Angstroms, a, b, c) 108.2,147.4,139.0
Unit cell angles (deg., a, b, g) 90,90,90
I/s (last shell) 15.0 (3.8)
Rsym (last shell) 0.103 (0.387)
Percentage completeness (last shell) 99.6 (99.6)
No. of reﬂections 392313
No. of unique reﬂections 38518
Redundancy (last shell) 5.0 (4.6)
Selenium phasing
No. of sites 22,27
Figure of merit 0.39
Reﬁnement
Resolution (Angstroms) 36–3.1
No. of reﬂections 38485
No. of working reﬂections








R.m.s.d. bond length (Angstroms) 0.003
R.m.s.d. bond angles (deg.) 0.618
Rsym=SSj|I j hIi/SIj, where Ij is the intensity of the measurement
for reﬂection j and hIi is the mean intensity for multiply-recorded
reﬂections.
Rwork,free=S||Fobs|-|F calc||/|Fobs, where the working and free
R-factors are calculated using the working and free reﬂection sets.
The free reﬂections were held aside during reﬁnement.
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over a Ni
2+-afﬁnity column, and the ﬂow-through col-
lected, concentrated and run over a Sephacryl S200 gel
ﬁltration column equilibrated in buffer SE. Fractions con-
taining the insert were identiﬁed by SDS–PAGE/
Coomassie staining, then pooled and concentrated by cen-
trifugal ﬁltration. Glycerol was added to a ﬁnal concen-
tration of 30%, and protein aliquots were ﬂash-frozen in
liquid nitrogen and stored at  80 C. Final storage condi-
tions were 50mM HEPES pH 7.5, 500mM KCl, 1mM
EDTA pH 8.0, 2mM bME, 30% glycerol.
Puriﬁcation of CTD-less E. coli GyrA
Puriﬁcation was carried out as for the GyrB insert, except
that a Sephacryl S300 size exclusion column was used and
equilibrated in buffer SE-200 (50mM HEPES pH 7.5,
200mM KCl, 1mM EDTA, 2mM bME, 10% glycerol).
Peak fractions were chosen by SDS–PAGE/Coomassie
staining, glycerol was added to a ﬁnal concentration of
19%, and protein aliquots were snap-frozen in liquid
nitrogen and stored at  80 C. Final storage conditions
were 45mM HEPES pH 7.5, 180mM KCl, 0.9mM
EDTA, 1.8mM bME, 19% glycerol.
Negative supercoiling assays
Negatively-supercoiled plasmid DNA [pSG483, a deriva-
tive of pBluescript (pBSK)] was puriﬁed using a
Macherey–Nagel maxiprep kit and relaxed with DNA
topo I prepared in-house from wheat germ (46).
Wild-type, GyrBinsert, GyrB–H669A or GyrB–H669E
gyrase tetramer at varying concentrations were each
incubated with 700ng (350fmol) plasmid in 20ml reactions
for 30min at 37 C. Assay conditions were 30mM Tris–
HCl pH 7.5, 30mM potassium glutamate, 2mM MgCl2,
7% glycerol, 1mM DTT and 1mM ATP, with an add-
itional  50mM potassium chloride and  3% glycerol
contributed from the protein storage buffer. Reactions
were stopped with the addition of 1% SDS and 10mM
EDTA (ﬁnal concentrations). Sucrose loading dye was
added to samples, and samples were run on a 1%
agarose, 0.5 TBE gel at 1–1.5V/cm for 14–18h. Gels
were stained with 0.5mg/ml ethidium bromide (EtBr) in
0.5 TBE for 30min, followed by a brief destaining in
0.5 TBE. Bands were visualized by UV transillumin-
ation.
Positive supercoil relaxation assays
Positively-supercoiled plasmid DNA (pSG483) was
prepared by treating relaxed plasmid with A. fulgidus
reverse gyrase as described by Rodriguez (47). Reactions
were carried out as described for negative supercoil
introduction.
Negative supercoil relaxation assays
Negatively-supercoiled plasmid DNA (pSG483) was
prepared using a maxiprep plasmid puriﬁcation kit
(Macherey–Nagel). Assays were carried out as described
earlier for negative supercoiling assays, except ATP was
omitted.
Cleavage assays
Negatively-supercoiled plasmid DNA (pBSK) was
prepared by CsCl centrifugation. Increasing amounts of
gyrase were incubated with 700ng (350fmol) pBSK for
30min in 20ml reactions at 37 C. Reaction conditions
were as follows: 30mM Tris–HCl pH 7.5, 30mM potas-
sium glutamate, 2mM MgCl2, 7% glycerol, 1mM DTT
and 1mM ciproﬂoxacin, with an additional  50mM KCl
and  3% glycerol contributed from the protein storage
buffer. Reactions were stopped by the addition of SDS
to 1%, followed by the addition of EDTA to 10mM.
Samples were incubated with 0.1mg/ml proteinase K for
1h at 37 C, combined with sucrose loading dye, and
loaded onto 1% agarose/0.5 TBE gels. Gels were run
at 1.5V/cm for 14–18h and stained with 0.5mg/ml EtBr
in 0.5 TBE for 30min. Gels were then destained brieﬂy
in 0.5 TBE and bands visualized by UV transillumin-
ation. A linearized pBSK standard was generated by
cleaving the negatively-supercoiled DNA with BamHI
(New England Biolabs).
DNA-binding assays
DNA binding was visualized by electrophoretic mobility
shift assays (EMSAs). The DNA substrate for binding was
a 50-bp segment of plasmid pBR322 shown previously to
contain a strong gyrase-binding site (48). Two comple-
mentary single-stranded oligos (50-GCG AGA AGA
ATC ATA ATG GGG AAG GCC ATC CAG CCT
CGC GTC GCG CAA CG-30;5 0-/6-FAM/ CGT TGC
GCG ACG CGA GGC TGG ATG GCC TTC CCC
ATT ATG ATT CTT CTC GC-30,where 6-FAM indicates
the position of a ﬂuorescein label for visualization) were
obtained from Integrated DNA Technologies and indi-
vidually resuspended in 100ml annealing buffer (10mM
Tris–HCl pH 7.5, 50mM KCl, 5mM MgCl2)t o
 500mM ﬁnal concentration. The two oligos were then
combined in equimolar amounts and annealed by
boiling in a 1l water bath for 5min and allowing the
bath to cool to room temperature overnight. Double-
stranded DNA was puriﬁed by native PAGE and stored
in annealing buffer.
Tetramericgyrasewasreconstitutedfromwild-type,in-
sert, H668A or H668E E. coli GyrB and E. coli GyrACTD
at varying concentrations and incubated with 75nM of the
labeled double-stranded 50mer for 30min at room tem-
perature in 25ml reactions containing 30mM Tris–HCl
pH 7.5, 2mM MgCl2, 6% glycerol, 1mM DTT; the
protein storage buffer contributed an additional  75mM
KCl and 4.5% glycerol. Reactions were loaded directly
onto a 1.8% low-melting temperature agarose gel
(SeaPlaque agarose, FMC Bioproducts). Gel running
buffer consisted of 45mM Tris–borate and 2.5mM
MgCl2. Gels were run for  3h at 4.3V/cm, and DNA
was visualized using a Typhoon ﬂuorescent scanner
(GE Healthcare), with excitation at 532nm.
ATPase activity assays
Wild-type and mutant gyrase ATPase activities were
measured using an established enzyme-coupled assay
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coupled to the oxidation of NADH to NAD
+. To deter-
mine standard kinetic parameters (KM, kcat), 0.2mM
tetrameric wild-type, GyrBinsert, GyrB–H669A or
GyrB-H669E gyrase was incubated with 0–3mM ATP in
75ml reactions. Reactions contained 50mM HEPES pH
7.5, 50mM KCl, 5mM MgCl2,5 m MbME, 0.1mg/ml
bovine serum albumin, 2mM phosphoenol pyruvate
(PEP), 0.2mM freshly-prepared b-nicotinamide adenine
dinucleotide (NADH), and an excess of pyruvate kinase
and lactate dehydrogenase (enzyme mix obtained from
Sigma). Assays were performed at 37 C. Oxidation of
NADH to NAD
+ was monitored by measuring absorb-
ance at 340nm in a Perkin Elmer Victor
3V 1420
multilabel plate reader. The rate of decrease in absorbance
was converted to micromoles of ATP hydrolyzed to ADP
using an NADH standard curve and the assumption that
one ATP is hydrolyzed for every NADH oxidized.
ATPase rate as a function of [ATP] was ﬁt for KM and
Vmax using Michaelis–Menten kinetics in KaleidaGraph
(Synergy Software).
DNA stimulation of ATPase activity was measured
using assays performed as described earlier, except that
the concentration of ATP was held constant at 0.5mM,
and reactions were supplemented with varying amounts of
sheared, puriﬁed salmon sperm DNA (Sigma) resus-
pended in 10mM Tris pH 7.5, 50mM KCl, 5mM MgCl2.
RESULTS
The E. coli GyrBA-fusion protein forms a homodimer
To ﬁrst visualize the GyrB insert in the context of the
DNA- and C-gates, we set out to crystallize the entire
212kDa DNA binding and cleavage core of E. coli
gyrase. To prevent subunit dissociation and simplify crys-
tallization, we constructed a fusion protein that couples
residues Ala388–Ile804 of E. coli GyrB directly to residues
Met1–Ser525 of E. coli GyrA, linking the two proteins
through their poorly-conserved C- and N-termini, respect-
ively. Similar subunit fusions have been shown previously
to support function of full-length topo IV and gyrase
(51,52). The fusion construct, hereafter termed GyrBA-
fus, includes the GyrB TOPRIM and insert, along
with the WHD, coiled-coil and C-gate domain of GyrA
(Figure 1A). Because GyrBA-fus lacks the GyrB ATPase
and GyrA C-terminal DNA-binding domains, it is unable
to supercoil DNA, but can support DNA cleavage (not
shown). We crystallized selenomethionine-derivatized
GyrBA-fus in space group C2221 and solved its structure
to 3.1A ˚ resolution. The ﬁnal model was reﬁned to Rwork/
Rfree values of 23.4/28.2%, with good stereochemistry
(Table 1).
Crystals of GyrBA-fus contain one monomer per asym-
metric unit. A crystallographic 2-fold axis recapitulates a
dimeric particle, in which the GyrA winged-helix and
C-gate domains form homomeric interactions as seen
in other structures of this region (Figure 2) (41,53–55,
PDBID 2INR). As expected, the E. coli GyrB TOPRIM
fold is similar in structure to homologous elements from
yeast and bacterial type IIA topos, except for the relative
position of a small C-terminal extension that emanates
from the central metal-binding domain. This region, some-
timestermed the ‘tail’ or‘hook,’ hasbeen shown previously
to be ﬂexible with respect to the TOPRIM core. In
GyrBA-fus, the hook adopts an orientation similar to
that seen in the isolated Mycobacterium tuberculosis GyrB
TOPRIM fold (56), which lies between more extreme con-
formational states observed for Saccharomyces cerevisiae
topo II and Streptococcus pneumoniae topo IV
(Supplementary Figure S1) (22,23,57,58). There is no
electron density visible for several amino acids at the
extreme C- and N-termini of the GyrB and GyrA regions,
respectively, indicating that the fusion has not constrained
the relative orientations of the two subunits.
The insert bears little resemblance to known protein
structures
Although the general shape and organization of the
GyrB insert has been analyzed by secondary-structure
analysis and small-angle x-ray scattering (SAXS) (35,36),
our model provides the ﬁrst high-resolution view of this
domain. The insert protrudes from the extreme tip of the
TOPRIM hook, away from the central metal-binding fold
(Figure 3A). The element is composed of three
subdomains: a short, four-stranded b-sheet packed
against a single a-helix (subdomain 1, residues Asp562–
Gly577 and Asp704–Arg732), a central three-helix bundle
(subdomain 2, Glu578–Thr616 and Gly684–Glu703),
and a longer three-stranded b-sheet packed against a
large helix (subdomain 3, residues Glu617–Thr683).
Topologically, subdomain 3 is the only region formed by
sequentially contiguous secondary structure elements
(Figures 1B and 3B).
The mixed a/b fold and extended shape of the insert is
largely in agreement with SAXS envelopes for the region,
although the fold is distinct from prior predictions (36).
Indeed, the overall fold of the GyrB insert appears to be
unique, with a DALI search using the isolated insert
domain revealing limited structural homology to a small
scattering of proteins, nearly all of which appear to be in-
cidental (Z-scores<5) (59). The best alignment (Z-score
4.4) is between a portion of the insert (subdomain 3) and
the C-terminal region of the Desulﬁtobacterium hafniense
tail sheath protein, which adopts a phage sheath 1 super-
family fold. This similarity encompasses only 50 amino
acids of the insert with a Ca r.m.s.d. of 2.6A ˚
(Supplementary Figure S2) (PDBID 3HXL).
The GyrBA-fus conformation resembles DNA-bound
type IIA topo states
There currently exist four models of the type IIA
topoisomerase DNA binding and cleavage core, two
solved in the absence of DNA and two in its presence
(22,23,57,58). These structures have shown that the
relative orientation of the TOPRIM domains, which con-
stitute a large portion of the DNA gate, can be extremely
plastic. Thus far, the TOPRIM domains have been
visualized in three distinct conformations relative to the
WHDs. In two of these states, both of which were
observed in DNA-free S. cerevisiae topo II, the position
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of a G-segment DNA (Figure 4) (57,58). In the third, seen
in the DNA-bound complexes of both topo II and S.
pneumoniae topo IV (22,23), the TOPRIM domains
ﬂank the G-segment-binding site, forming a portion of
the long channel that comprises the primary DNA inter-
action surface. Surprisingly, the TOPRIM domains of
DNA-free GyrBA-fus adopt a conformation analogous
to that seen in DNA-associated type IIA topo models
(Figure 4). This observation demonstrates that the DNA
gate of E. coli gyrase can adopt a properly conﬁgured
DNA-binding conformation even in the absence of
nucleic acid substrate.
The insert plays a role in DNA supercoiling and
relaxation, but not cleavage
Previous biochemical studies of the E. coli GyrB insert
have shown that this region is necessary to support
normal gyrase function (35). The effects of deleting this
region were severe, resulting in a 50-fold reduction in
supercoiling activity and an 80-fold reduction in
drug-induced cleavage activity. Based on our present
structure, we reexamined the truncation end points used
for this analysis (amino acids Leu561–Glu720) and found
that they cut within the middle of the subdomain 1
hydrophobic core. To test whether the inclusion of these
extra residues might have inadvertently impaired gyrase
activity indirectly (e.g. by promoting subunit aggregation,
mis-assembly or misfolding), we used the GyrBA-fus
model to guide the construction of a more precise insert
deletion, replacing residues Thr565-Arg731 of E. coli
GyrB with a short, ﬂexible linker (Gly–Ser–Ser–Gly).
To rule out the possibility that preparations of this
truncated construct (hereafter termed GyrBinsert) might
be contaminated with endogenous, wild-type GyrB, we
carried out supercoiling assays that varied the relative
ratio of GyrB or GyrBinsert to GyrA. Brieﬂy, the
amount of GyrB or its variants was titrated against a
constant amount of GyrA, and the supercoiling activity
of the mixture assessed by agarose gel electrophoresis and
ethidium bromide staining. Consistent with our estimate
of sample purity by SDS–PAGE (>98%), maximal
activity was observed at a ratio of one GyrBinsert
subunit to one GyrA protomer (not shown), indicating
that little or no native GyrB copuriﬁed with the mutant
subunit. We also examined puriﬁed GyrB and GyrBinsert
proteins by circular dichroism and found the spectral sig-
nature of the mutant to be virtually identical to wild-type
(not shown). This result indicates that removal of the
insert did not appreciably alter the secondary structure
Figure 2. GyrBA-fus structure. The structure of the GyrBA-fus dimer is shown in cartoon. Subdomains are colored as indicated. One protomer
is shown in gray, except for the a carbons of the catalytic tyrosines, both of which are represented as magenta spheres. This and other structure
ﬁgures were prepared in PyMOL (71).
7836 Nucleic Acids Research, 2010,Vol.38, No. 21of the protein, as would be expected if the mutant had
severely perturbed proper folding.
To ascertain the functional effects of removing the
GyrB insert, we reconstituted tetrameric gyrase from
wild-type E. coli GyrA and either wild-type or truncated
GyrB. The holoenzyme was pre-formed by ﬁrst incubating
equimolar amounts of GyrB and GyrA at high concen-
tration ( 10mM) on ice for at least 15min. Both proteins
were then subjected to a battery of gyrase activity assays,
including: (i) positive supercoil relaxation and negative
supercoil introduction (both ATP-dependent), (ii) the
ATP-independent relaxation of negative supercoils, and
(iii) drug-induced DNA cleavage.
To assess negative supercoiling, we incubated relaxed
plasmid DNA with increasing amounts of wild-type or
GyrBinsert gyrase in the presence of ATP, and visualized
the resulting products by gel electrophoresis. Comparison
of the relative enzyme concentrations needed to produce
comparable levels of supercoil introduction indicates
that precise deletion of the insert reduces supercoiling
activity  20- to 30-fold (Figure 5A). A similar degree of
impairment was seen in the ability of GyrBinsert gyrase
to relax (and subsequently negatively supercoil) a
positively-supercoiled plasmid substrate (Figure 5B). In
ATP-independent relaxation reactions using negatively-
supercoiled substrate, the truncation mutant again
displayed an activity  25-fold down relative to wild-type
gyrase (Figure 5C). Thus, in agreement with Chatterji
et al. (35), the GyrB insert appears to be generally import-
ant for gyrase reactions that require strand passage.
We next set out to deﬁne the role of the insert in DNA
cleavage. In all type IIA topos, cleavage is disfavored
compared to ligation; however, certain drugs, such as
ﬂuoroquinolones, can stabilize cleavage complexes
(60,61). We incubated increasing amounts of wild-type
or GyrBinsert gyrase with plasmid DNA and 1mM of
the ﬂuoroquinolone ciproﬂoxacin. Protein was removed
from the reactions using proteinase K, and the resulting
products visualized by agarose gel electrophoresis and
ethidium bromide staining. In contrast to its strong
effects on supercoiling, the GyrBinsert gyrase showed a
relatively modest cleavage defect ( 6-fold) compared to
wild-type gyrase (Figure 5D). This discrepancy may be
due to the fact the cleavage assay represents an endpoint
reporter that relies on the trapping of a drug-induced
cleavage state; hence, the long-term build-up of linear
DNA may not accurately reﬂect differences in activity
Figure 4. Relative TOPRIM orientations. Side view of GyrBA-fus
(lower-right panel) shown next to models for three other conformations
of the type IIA topo DNA binding and cleavage core (top two panels—
apo S. cerevisiae topo II, PDB ID BGW and PDB ID 1BJT; lower
left panel—DNA-bound S. cerevisiae topo II, PDB ID 2RGR).
The arrow marks the open G-segment-binding channel in GyrBA-fus.
One protomer of each dimer is colored gray; the other is colored as per
Figure 1A.
Figure 3. GyrB insert structure and organization. (A) Insert/TOPRIM
orientation. The E.coli GyrB TOPRIM is shown aligned with a
DNA-bound form of the S. cerevisiae topo II TOPRIM [PDB ID
2RGR (22)]. (B) Insert substructure. The three subdomains of the
insert are shown and labeled as per Figure 2.
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that the observed reduction in supercoiling activity might
be linked to one or more speciﬁc defects in enzyme
function, rather than DNA cleavage per se.
Removal of the insert reduces DNA-binding afﬁnity and
DNA-stimulated ATPase activity
To examine this issue further, we next asked if the insert
affects DNA binding. To compare the relative afﬁnities of
wild-type and GyrBinsert gyrase for DNA, we incubated
a ﬂuorescein-labeled 50-bp duplex oligonucleotide corres-
ponding to the pBR322 strong gyrase-binding site with
increasing concentrations of gyrase tetramer formed
from either wild-type or insert-deleted GyrB. A GyrA
construct lacking its C-terminal domain (GyrACTD)
was used in this assay to avoid competition from the
CTD in G-segment binding. Complexes were visualized
by an EMSA in a native agarose gel (Figure 6A). We
found that DNA binding by GyrBinsert gyrase was sub-
stantially (at least 30- to 50-fold) lower than wild-type.
This result is consistent with previous studies, which
found a complete abrogation of DNA-binding afﬁnity
upon removal of the insert (35). It should be noted,
however, that these assays were carried out using a small
DNA fragment rather than a plasmid substrate, a differ-
ence that may accentuate the DNA-binding defect
compared than DNA cleavage, relaxation or supercoiling
activities.
The loss of DNA afﬁnity in the truncation, together
with its impaired biochemical functions, suggested that
the insert’s predominant role is in facilitating DNA
binding. To ascertain whether this function might be due
to direct or indirect interactions with nucleic-acid
segments, we puriﬁed the isolated insert domain and
tested its ability to bind DNA by both non-equilibrium
Figure 5. Comparison of wild-type and GyrBinsert gyrase activities. Negative supercoiling assays (A), positive supercoil relaxation assays
(B), negative supercoil relaxation assays (C) and ciproﬂoxacin-dependent DNA cleavage assays (D) were carried out as described (‘Materials and
Methods’ section). The enzyme (wild-type or GyrBinsert gyrase) used in each titration is shown at left. Positions of relaxed and supercoiled species
are indicated at right. Lanes with negatively supercoiled (–SC) or BamHI-linearized (L) plasmid standards are indicated, as are the concentrations of
gyrase tetramer (in nM). Asterisks indicate lanes in each pair of gels with comparable activities. In the cleavage assay (D), the rightmost lane contains
a DNA ladder (O’GeneRuler, Fermentas) with the standard sizes (in kb) indicated.
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methods. In neither instance was any evidence of DNA
binding detectable, even at a 50-fold molar excess of
protein (not shown). This result indicates that if the
insert does interact with nucleic acid segments, it likely
does so only in the context of the holoenzyme.
Finally, we examined the ATPase activity of wild-type
and GyrBinsert gyrase using a coupled spectrophoto-
metric assay in which ATP hydrolysis is linked to the
oxidation of NADH to NAD
+ by the sequential action
of pyruvate kinase and lactate dehydrogenase (49).
Unexpectedly, we found that rather than reducing the
basal ATPase activity of gyrase, removal of the GyrB
insert actually moderately increased kcat by 2-fold and
decreased KM  3-fold (Figure 6B and Table 2). By
contrast, whereas DNA stimulated wild-type gyrase
ATPase activity by 10- to 15-fold (Figure 6C), it complete-
ly failed to affect GyrBinsert gyrase. Given the observed
loss of DNA binding by GyrBinsert, it is likely that this
behavior arises, at least in part, from an inability of the
mutant to properly bind a G-segment duplex.
Structure-based phylogenetic analysis of a coupling
point between the insert and GyrA
Because ablation of an entire domain is a somewhat
extreme physical alteration, we next focused on how
speciﬁc structural contacts between the insert and the
rest of gyrase affect enzyme function. In the context of
GyrBA-fus, the insert forms a curved ‘handle’ that pro-
trudes out and away from the core TOPRIM domain
(Figure 2). Remarkably, the insert forms essentially no
contacts with other parts of gyrase, except between a
small loop within insert subdomain 3 (residues 667–669)
and the proximal end of the GyrA colied-coil region.
To determine whether this interaction or other regions
of the insert might be important for gyrase function, we
conducted a phylogenetic analysis of the E. coli GyrB
insert using INTREPID (INformation-theoretic TREe
traversal for Protein functional site IDentiﬁcation) (62).
The INTREPID algorithm weights sequence homology
within clusters that are closely related to the target
protein more heavily than global homology overall and
thus displays improved sensitivity in identifying functional
residues that are speciﬁc to orthologous subgroups. The
mapping of INTREPID scores (Supplementary Table S1)
for the GyrB insert onto our structure allowed visualiza-
tion of potentially important sites. While the majority of
these sites corresponded to buried hydrophobic residues,
one of the highest-scoring residues, His669, mediates the
Figure 6. DNA binding and ATPase activity of wild-type and
GyrBinsert gyrase. (A) EMSAs. Titration of wild-type GyrB:
GyrACTD is shown at top; the GyrBinsert:GyrACTD construct, at
bottom. Arrows indicate the positions of free DNA (F) and
DNA-protein complex (C). Values above each lane indicate the
amount of tetramer innM. (B) Basal ATPase activity. Wild-type and
GyrBinsert gyrase activities are plotted as a function of ATP concen-
tration and ﬁt to a standard Michaelis–Menten kinetic model.
(C) DNA-stimulated ATPase activity. Wild-type and GyrBinsert
gyrase activities at a constant ATP concentration are plotted as a
function of sheared salmon sperm DNA concentration. Data for
wild-type gyrase are ﬁt to a single-site binding equation; GyrBinsert
gyrase data are ﬁt to a line.
Table 2. Basal ATPase activity of wild-type, insert, H669A and
H669E gyrase






Errors are standard deviations from at least three measurements.
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coiled-coil (Figure 7).
We therefore mutated His669 to alanine and glutamic
acid and tested both variants for supercoiling, DNA
binding and ATPase activity. Endogenous GyrB contam-
ination was controlled for as described for GyrBinsert.
The H669A mutant behaved like wild-type gyrase in all
respects (not shown); however, the H669E substitution did
not. Most notably, theH669E mutation reduced negative
supercoiling activity  5-fold (Figure 8A). Gyrase-H669E
displayed wild-type ciproﬂoxacin-dependent DNA
cleavage (Figure 8B) and DNA binding (Figure 8C), but
exhibited a 50% reduction in basal (non-DNA-stimulated)
ATPase activity (Figure 8D) and a modest defect in
DNA-stimulated ATPase activity (Figure 8E). Taken
together, these results suggest that the contact point
between the insert and GyrA does not directly participate
in the formation of structural or chemical states important
for DNA binding or cleavage, but that it does play a role
in ATPase and strand passage functions.
DISCUSSION
The gyrB genes of numerous bacterial species, particularly
those of gram-negative organisms, are distinguished by the
presence of a moderately-sized insertion embedded within
the TOPRIM fold of the subunit (Figure 1). To begin to
understand the role of this region in gyrase’s mechanism,
we have determined the structure of the insert, together
with the accompanying DNA binding and cleavage core of
E. coli gyrase. This structure constitutes the ﬁrst view of
the complete DNA gate of a topo from this important
model organism, as well of the insert in general.
Furthermore, the model reveals that the insert adopts a
novel fold that protrudes from the TOPRIM hook
subdomain, contacting the associated GyrA subunit at a
point near the base of its coiled-coil elements (Figures 2
and 3). Since the poor sequence conservation of the insert
and its sporadic presence throughout the bacterial
kingdom have hindered efforts to probe its function, we
used the structure to guide targeted mutagenesis and bio-
chemical studies. An insert-deletion mutant (GyrBinsert)
markedly reduced DNA supercoiling and relaxation
( 25-fold), but impacted DNA cleavage less severely
(Figure 5). The insert also proved necessary for both
DNA binding and DNA-dependent stimulation of
ATPase activity (Figure 6); however, the domain in isola-
tion did not appear capable of interacting with a short
DNA duplex. Consistent with this result, modeling of a
G-segment DNA (as it appears in a co-crystal structure
with S. cerevisiae topo II) onto our structure reveals no
contacts between the insert and the nucleic acid segment
(Supplementary Figure S3).
Together, these results argue that the insert’s contribu-
tion to G-segment binding is indirect. One mechanism
through which the insert may affect this property is by
reducing the conformational space available to the
TOPRIM domain, predisposing it to adopt an orientation
that, until now, has been observed exclusively in
DNA-bound forms of type IIA topos (Figure 4) (22,23).
Figure 7. Insert/GyrA interactions. (A) INTREPID analysis. The
structure of GyrBA-fus is shown as in Figure 2, except the insert is
displayed as a surface model and colored by INTREPID score
(Supplementary Table S1) (62). (B) GyrB His669 contacts GyrA. The
GyrB insert is shown colored by INTREPID score; the GyrA
coiled-coil is shown in blue. Selected amino acids in close proximity
are shown in stick/transparent spheres representation and colored by
atom.
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insert from our present structure onto DNA-free models
of topo II, neither of which appear capable of binding
an intact G-segment DNA, results in signiﬁcant clashes
between the insert and the rest of the protein
(Supplementary Figure S4). Thus, the insert appears to
function in part as a steric buttress, stabilizing the
DNA-gate of gyrase in a conformation that favors
G-segment binding (Figure 9). It is interesting to note
that this role appears to speciﬁc to those topos that bear
the insert (such as E. coli), as otherwise ortholologous
enzymes lacking this element are not obviously impaired
functionally. We hypothesize that these ‘insert-less’ topos,
which comprise the bulk of type IIA topo homologs,
possess sequence variations or structural differences that
stabilize the formation of a competent DNA-binding state
without the need for this domain.
The poor sequence conservation of the insert likewise
supports the notion of a primarily structural role for this
domain; however, we were able to uncover one function-
ally signiﬁcant, surface-exposed residue in the region
(His669) using INTREPID, a phylogenetic tree-based al-
gorithm for scoring amino acid sequence conservation. In
the GyrBA-fus structure, His669 sits at the apex of a loop
that forms the only contact between the insert and GyrA
(Figure 7). When His669 is mutated to glutamic acid, the
Figure 8. GyrB H669E activities. Negative supercoiling assays (A) and ciproﬂoxacin-dependent DNA cleavage assays (B) are shown and labeled with
the enzyme (wild-type or GyrB-H669E gyrase) used in each titration. Positions of relaxed and supercoiled species are indicated, as are lanes with
negatively supercoiled (–SC) or BamHI-linearized (L) plasmid standards. The concentrations of gyrase tetramer (innM) are also shown. Asterisks
indicate lanes with comparable activity for each pair of gels. In the cleavage assay (B), the rightmost lane contains a DNA ladder (O’GeneRuler,
Fermentas) with the standard sizes (in kb) indicated. (C) DNA binding. Arrows indicate the positions of free DNA (F) and protein-DNA complex
(C) in the EMSA. Values indicate the amount of tetramer innM. (D) Basal ATPase activity. The ATPase activities of wild-type (circles) and GyrB–
H669E (triangles) gyrase are plotted as a function of ATP concentration and ﬁt to a standard Michaelis–Menten kinetic model. (E) The ATPase
activities of wild-type (circles) and GyrB–H669E (triangles) gyrase at a constant ATP concentration are plotted as a function of increasing amounts
of sheared salmon sperm DNA. Data are ﬁt to a single-site binding equation.
Nucleic Acids Research, 2010,Vol.38, No. 21 7841resultant gyrase lost  50% of its ATPase activity and
 80% of its negative supercoiling activity (Figure 8).
In contrast, the H669E mutant was normal for DNA
binding and cleavage and retained its DNA-stimulated
ATPase activity.
Thus,whilethesimplephysicalpresenceoftheinsertaids
DNA binding by gyrase, the insert-mediated connection
between the TOPRIM and the GyrA coiled coil regions
appears important for the strand passage reaction overall.
One means by which the insert could assist this event is by
binding T-segment DNA; however, we see no particular
attractive (e.g. electropositive) surface that might mediate
such a function (Supplementary Figure S3), nor did the
insert show any propensity to engage nucleic acids
in vitro. Alternatively, the insert might play a role in
strand passage by aiding communication between holoen-
zyme gates. The promotion of unidirectional strand
passage by type IIA topos is known to require the
physical and temporal coordination of structurally dispar-
ate functional modules (2). For example, in the homolo-
gous ATPase regions of topo II and topo VI (a type IIB
enzyme), a conserved lysine (Lys337 in E. coli GyrB) has
been suggested to mediate communication between the
ATP- and DNA-gates, contacting the g-phosphate of
ATP and inducing conformational changes in response to
ATP hydrolysis (63–66). The GyrB insert may constitute a
similar, albeit non-catalytic, structural relay between the
DNA-gate and either the ATP- or C-gate to communicate
conformational signals between these structurally distinct
protein interfaces (Figure 9).
As there have been relatively few systematic compari-
sons of gyrases from different organisms, it is difﬁcult to
assign a conserved role for the insert among the many
species in which it appears. The presence of the domain
in the deeply-rooted hyperthermophilic genus Aquifex (67)
suggests that the insert may have been present in early
GyrB genes and subsequently lost in the majority of bac-
terial lineages. Where it has been retained, species-speciﬁc
variations, such as residue His669 in the proteobacterial
GyrBs, may have contributed to the biochemical function-
ality of this element, promoting its retention despite the
cost of maintaining such a relatively large protein compo-
nent. Alternatively, it is possible that the insert may have
been acquired through horizontal gene transfer to serve
some as yet undeﬁned role in the cell. In the future, it
will be important to determine whether gyrases lacking
this region have acquired compensatory mutations that
stabilize the TOPRIM domain orientation or promote
DNA binding. Moreover, it will be interesting to see if
the GyrB insert serves as a platform for associating
with speciﬁc regulatory proteins. Additional structural
information, preferably in the presence of DNA and
larger constituent pieces of the holoenzyme, should help
further elucidate the precise mechanism through which the
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